OS Therapies Incorporated (OSTX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

OS Therapies Incorporated (OSTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $84.2M, listed on AMEX, employing roughly 4 people, carrying a beta of -1.34 to the broader market. OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Led by Paul A. Romness, public since 2024-08-01.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for OSTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →